With more than 9.55 billion COVID-19 vaccines doses administered*, the post COVID-19 pandemic recovery and other geopolitical events in 2021 has left the healthcare & life sciences industry in a remarkable position to be ready for 2022 and beyond. As healthcare consumerism continues to boom, our research forecasts the global healthcare & life sciences industry to hit revenues of $2.7 trillion by 2025.
Let's ask an intriguing question: How can manufacturers continue to drive momentum on increased operational revenues and patient engagement initiatives to sustain the top-line industry growth?
Frost & Sullivan has identified ten dynamic growth opportunities that will have an unquestionable impact on three merging drivers of change; Precision Care, Hospital to Home & Digital Front Doors- all important elements of agility in pushing the envelope to launch innovative services and solutions.